BCPP

Brief about this service

BCPP supports breast lesion characterization and treatment-pathway planning through a focused marker framework.

Breast Comprehensive Prognostic Panel focused on receptor and biomarker-driven breast oncology decisions. Each case is processed under quality-controlled oncology diagnostics workflows for clinically meaningful output.

When this test is commonly used

• Breast tumor cases requiring focused receptor and prognostic marker interpretation.
• Cases where integrated marker context is needed for therapy-direction planning.
• Workflows requiring concise breast-oncology biomarker reporting.

Sample and reporting guidance

Share specimen type, prior findings, and clinical question clearly so the test pathway and reporting focus can be aligned early.

Reports are structured for doctor readability with concise interpretation notes and pathway-oriented communication.